Issue 5/2021

The role of the primary cilium in cancer (899 — 906)

Hong-Tai Cao, Miao-Miao Liu, Quan-Nian Shao,  Zuo-Yi Jiao

DOI: 10.4149/neo_2021_210210N204

The role of corticotropin-releasing hormone (CRH) family in tumors (907 — 916)

Su-Qin Yi, Jia-Xing An, Cheng-Cheng Liao, Sha Lei, Hai Jin,  Bi-Guang Tuo

DOI: 10.4149/neo_2021_210219N226

PPM1H is an independent prognostic biomarker of non-small cell lung cancer (917 — 923)

Wen-Qi Zhang, Jian-Nan Gao, Xiang-Lei Chen,  Xi-Feng Yang

DOI: 10.4149/neo_2021_201117N1238

Homoharringtonine inhibits the progression of hepatocellular carcinoma by suppressing the PI3K/AKT/GSK3β/Slug signaling pathway (924 — 937)

Hong-Yuan Liu, Tian-Xiu Dong, Zi-Zhuo Li, Tian-Tian Li, Jian Jiang, Ming-Wei Zhu, Ting-Ting An, Yao-Dong Chen,  Xiu-Hua Yang

DOI: 10.4149/neo_2021_210113N57

Tumor-associated macrophages increase COX-2 expression promoting endocrine resistance in breast cancer via the PI3K/Akt/mTOR pathway (938 — 946)

Qi Qin, Hongfei Ji, Dongbo Li, Han Zhang, Ziwen Zhang,  Qingyuan Zhang

DOI: 10.4149/neo_2021_201226N1404

Claudin14 promotes colorectal cancer progression via the PI3K/AKT/mTOR pathway (947 — 954)

Tian-Yu Qiao, Zi-Ming Yuan, Tian-Yi Ma, Han-Qing Hu, Yi-Hao Zhu, Wei-Yuan Zhang, Qian Zhang, Rui Huang, Qing-Chao Tang,  Gui-Yu Wang,  Xi-Shan Wang

DOI: 10.4149/neo_2021_210210N203

Determining the effects of Ephrin Type B Receptor 6 and Type A Receptor 3 on facilitating colorectal epithelial cell malignant transformation (955 — 964)

Jiaming Wang, Yan Zhang, Jiaao Ma, Cheng Yang, Muhong Wang, Jiachen Lv, Yihui Wang, Dazhuang Miao, Yan Wang, Mingqi Li, Cuicui Chai, Shixiong Jiang, Jinxue Tong,  Mingzhe Li,  Zhiwei Yu

DOI: 10.4149/neo_2021_210309N304

Novel long noncoding RNA Linc1749808 promotes hepatocellular carcinoma metastasis by negatively regulating miR-206 (965 — 974)

Yi Liu, Yuan Gao, Si-Yuan Wu, Le Ma, Chun-Fu Zhu,  Xu-Dong Zhang

DOI: 10.4149/neo_2021_210310N314

Nilotinib, a Discoidin domain receptor 1 (DDR1) inhibitor, induces apoptosis and inhibits migration in breast cancer (975 — 982)

Shuai Wang, Yanping Xie, Aina Bao, Jing Li, Tingting Ye, Chu Yang,  Shufang Yu

DOI: 10.4149/neo_2021_201126N1282

Alpha-fetoprotein/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells (983 — 993)

Huan Chen, Gui-Mei Chen, Yu-Juan Liu, Jian-Xu Rao, Si-Zhen Zhou, Shuang Chen, Ping-Ting Chen, Fang-Wan Yang, Qi-Jiao Cheng,  Yi-Huai He

DOI: 10.4149/neo_2021_210205N180

Alternations of N-glycans recognized by Phaseolus vulgaris leucoagglutinin in the saliva of patients with breast cancer (994 — 1004)

Jiajun Yang, Tianran Ma, Hanjie Yu, Mengqi Yin, Yan Qiao, Lili Niu, Fuquan Yang,  Jianjun He,  Zheng Li

DOI: 10.4149/neo_2021_210301N264

VRK1 promotes proliferation, migration, and invasion of gastric carcinoma cells by activating β-catenin (1005 — 1014)

Li Wang, Rujun Zhai, Hong Shen, Guodong Song, Fangxin Wan,  Qiang Li

DOI: 10.4149/neo_2021_210304N278

Hypoxia facilitates the proliferation of colorectal cancer cells by inducing cancer-associated fibroblast-derived IL6 (1015 — 1022)

Ying Xu, Rong Kuai, Yi-Min Chu, Lu Zhou, Hai-Qin Zhang,  Ji Li

DOI: 10.4149/neo_2021_210308N296

Co-expression of CD24 and Hsp70 as a prognostic biomarker for lung cancer (1023 — 1032)

Xiao-Juan Qiao, Yan Gu, Hua Du, Zhi-Wei Xing, Bu-Huan Ma, Wei-Ting Sun, Jing-Feng Yu,  Cai-Xia Liu

DOI: 10.4149/neo_2021_210118N81

Cyclin-dependent kinase like 3 promotes triple-negative breast cancer progression via inhibiting the p53 signaling pathway (1033 — 1042)

Dong-Xiang Zeng, Gui-Feng Sheng, Yong-Ping Liu, Ya-Ping Zhang, Zheng Qian,  Zhe Li,  Yan-Zhi Bi

DOI: 10.4149/neo_2021_210331N427

HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway (1043 — 1051)

Hengjie Ren,  Liyun Tang

DOI: 10.4149/neo_2021_210317N356

An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction (1052 — 1062)

Dong-Liang Yang, Lin-Fei Dong, Yin-Bing Qiu,  Gen-Yan Luo

DOI: 10.4149/neo_2021_210121N100

Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway (1063 — 1071)

Qiu-Yu Lin, Qian-Le Qi, Sen Hou, Zhen Chen, Nan Jiang, Laney Zhang,  Cheng-He Lin

DOI: 10.4149/neo_2021_210304N276

Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia (1072 — 1078)

Ming Wu,  Zi-Wen Guo, Gui-Nian Huang, Yong-Bin Ye

DOI: 10.4149/neo_2021_201230N1426

Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy (1079 — 1090)

 Aykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, Baran Mollavelioglu, Semen Onder, Selman Emiroglu, Mustafa Tükenmez, Mahmut Muslumanoglu, Abdullah Igci, Gunnur Deniz,  Vahit Ozmen Ozmen

DOI: 10.4149/neo_2021_210127N141

Genetic and phenotypic characteristics of Russian patients with BRAF-mutated colorectal cancer (1091 — 1097)

Anna Loginova, Yuri Shelygin, Vitaly Shubin, Sergey Achkasov, Alexey Ponomarenko,  Dmitry Shakhmatov, Sergey Skridlevskiy, Yuri Vaganov, Vladimir Kashnikov,  Alexey Tsukanov

DOI: 10.4149/neo_2021_210204N175

Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors (1098 — 1106)

Hai-Xiao Tang, Hao Yang, Feng Li, Zhi-Lie Cao,  Yun-Teng Huang,  Xiao-Ping Qi

DOI: 10.4149/neo_2021_210330N419

High-grade serous ovarian carcinoma and detection of inactivated BRCA genes from biopsy material of Slovak patients (1107 — 1112)

 Katarína Janíková, Barbora Váňová, Marián Grendár, Marek Samec, Alenka Líšková, Dušan Loderer, Ivana Kašubová, Anna Farkašová, Karla Scheerova, Pavol Slávik, Zora Lasabová, Zuzana Danková, Lukáš Plank

DOI: 10.4149/neo_2021_210226N256

Preoperative risk factors and recommendations for surgical intervention in cN0 papillary thyroid microcarcinoma (1113 — 1117)

Chang Liu,  Hui Liu, Cong Bian, Xi-Yu Yao, Yu Wu, Shun-Jin Chen, Shu-Ping Wu

DOI: 10.4149/neo_2021_210314N330